NCT07481851 Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients
| NCT ID | NCT07481851 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
| Condition | Hypotension |
| Study Type | OBSERVATIONAL |
| Enrollment | 102 participants |
| Start Date | 2025-12-22 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 102 participants in total. It began in 2025-12-22 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Spinal anesthesia-induced hypotension is a common and clinically significant complication in elderly patients undergoing oncologic surgery. Early identification of patients at risk for hemodynamic instability remains a major challenge in perioperative management. Skin conductance reflects sympathetic nervous system activity and may provide a noninvasive indicator of autonomic responses. This prospective observational study aims to evaluate whether skin conductance measurements can predict the development of hypotension following spinal anesthesia in geriatric oncology patients undergoing urologic surgery. The findings may contribute to improved perioperative monitoring and early risk stratification in this vulnerable patient population.
Eligibility Criteria
Inclusion Criteria: * Patients aged 65 years and older * Patients scheduled for elective urologic oncology surgery under spinal anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Patients who provide written informed consent to participate in the study Exclusion Criteria: * Refusal to participate or inability to provide informed consent * Contraindication to spinal anesthesia (e.g., infection at puncture site, coagulopathy) * Severe cardiac conduction abnormalities or presence of a cardiac pacemaker * Severe autonomic dysfunction or known neuropathy affecting autonomic responses * Use of medications that significantly affect autonomic nervous system activity * Baseline hypotension or hemodynamic instability before spinal anesthesia * Inability to obtain reliable skin conductance measurements (e.g., severe skin lesions at electrode placement site)
Frequently Asked Questions
Who can join the NCT07481851 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Hypotension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07481851 currently recruiting?
Yes, NCT07481851 is actively recruiting participants. Visit ClinicalTrials.gov or contact Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital to inquire about joining.
Where is the NCT07481851 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07481851 clinical trial?
NCT07481851 is sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. The trial plans to enroll 102 participants.